Evolve Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$554K Buy
1,432
+82
+6% +$30.4K 0.03% 472
2026
Q1
$395K Sell
1,350
-298
-18% -$97.9K 0.02% 678
2025
Q4
$578K Buy
+1,648
New +$557K 0.03% 477

Other funds holding ELV

Evolve Private Wealth's ELV Position: Q2 2026 in Review

Evolve Private Wealth increased its Elevance Health (ELV) stake by 6.1% in Q2 2026, buying an estimated $30.4K and bringing the position to 1,432 shares worth $554K. The position accounts for 0.03% of the portfolio, ranked #472.

Evolve Private Wealth first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $578K in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Evolve Private Wealth held 1,432 shares of Elevance Health worth $554K as of Q2 2026.
  • Evolve Private Wealth bought 82 Elevance Health shares in Q2 2026, an estimated $30.4K.
  • Elevance Health made up 0.03% of Evolve Private Wealth's portfolio in Q2 2026, its #472 holding.
  • Evolve Private Wealth first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Elevance Health position peaked at $578K in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.